In recent years, analysis of the culture filtrates of actinomycetes has resulted in the identification of a number of protein inhibitors of relatively low molecular mass (Umezawa, 1982). Eventually such compounds may well be developed as drugs since abnormal proteolysis mediates a number of human diseases (Barrett, 1980). As part of a search for further proteolytic enzyme inhibitors produced by micro-organisms we have identified and purified a chymotrypsin inhibitor (SCI) from culture filtrates of Streptomyces chrestomyceticus.
In recent years, analysis of the culture filtrates of actinomycetes has resulted in the identification of a number of protein inhibitors of relatively low molecular mass (Umezawa, 1982) . Eventually such compounds may well be developed as drugs since abnormal proteolysis mediates a number of human diseases (Barrett, 1980) . As part of a search for further proteolytic enzyme inhibitors produced by micro-organisms we have identified and purified a chymotrypsin inhibitor (SCI) from culture filtrates of Streptomyces chrestomyceticus.
Initial observations showed that the culture filtrates from stationary phase cultures of S . chrestomyceticus were capable of inhibiting a-chymotorypsin. The inhibiting material was purified by the following procedure. Dried material from 200ml of culture filtrates was dissolved in ammonium bicarbonate solution (10 mM) and passed through a column of Sephadex (3-15 equilibrated in the same buffer. Eluted fractions were monitored for inhibitory activity against a-chymotrypsin and those showing inhibiting activity were pooled, dried by rotary evaporation, and re-dissolved in water. The sample was then loaded on to sheets of Whatman no. 3 MM paper and electrophoresed at 3kV for 1.5h at pH 3.5 (pyridine/acetic acid/water, 1 : 10: 189, by vol.). inhibitory activity remained with the neutral material which was easily apparent as a brown band on the electrophoretogram. This neutral material was eluted with distilled water and loaded on to sheets of Whatman no. 3 MM paper and developed by descending chromatography in butanol/pyridine/acetic acid/water ( 1 5 : 10 : 3 : 12, by vol.), until the solvent front had moved a distance of 20cm. Active material, detected between 16 and 19cm from the origin, was eluted with distilled water and used for characterization and enzyme inhibition studies.
When dried, SCI is a white powder that is readily soluble in water. Studies on the activity of SCI against a-chymotrypsin and other classes of proteolytic enzymes are shown in Table 1 . At levels that produced significant inhibition of chymotrypsin, papain and ficin were the only other enzymes to be affected, albeit to a considerably lesser degree (Table I) . At higher concentrations inhibition of trypsin was also observed, but no effect was observed on carboxypeptidase A or pepsin. SCI therefore appears to inhibit both serine and Abbreviations used: SCI, chymotrypsin inhibitor from culture filtrates of Streptomyces chrestomyretirus; dansyl. 5-dimethylaminonaphthalene-1 -sulphonyl. 733 thiol endopeptidases active in the neutral pH range. The ability to inhibit a-chymotrypsin and to a lesser extent papain is similar to the specificity of chymostatin, a chymotrypsin inhibitor produced by a number of Streptomyces species (Umezawa, 1976) . SCI was therefore compared with a commercially available sample of chymostatin (Sigma). chromatography on silica gel in butanol/methanol/water (4: 1 : 2. by vol.) showed SCI to have an R, of 0.52 and chymostatin to have an R , of 0.59. Chromatography on paper in butanol/pyridine/acetic acid/water ( 1 5 : 10 : 3 : 12, by vol.) gave an R , for SCI of 0.84 and for chymostatin of 0.91. Both compounds were located on chromatograms both by reaction with the starch/KI stain and by their inhibitory activity. Additionally, unlike SC 1 chymostatin has been reported not to inhibit trypsin (Umezawa, 1976) , and the ease of solubility of SCI in water contrasts with the difficulty of dissolving chymostatin in water (Umezawa, 1976; H. Umezawa, personal communication) . The evidence therefore indicates that SCl and chymostatin are not identical, although their spectra of enzyme inhibition are similar. Kinetic studies showed SCI to be a non-competitive inhibitor of a-chymotrypsin.
With regard to the structure of SCI, a positive result with the starch/Kl stain showed SCI to be either partly peptidic or polysaccharide in nature. The presence of N-terminal amino groups could not be demonstrated by the dansyl method. Its elution position on Sephadex GI5 approximately midway between the included and excluded volumes suggested a molecular mass in the range 30G600 daltons. This molecular mass range encompasses nearly all the low molecular mass protease inhibitors indentified from microorganisms. Boiling the inhibitor for 5 min at pH 7.5 resulted in no loss of inhibitory action, nor was the inhibitory action lost by repeated freeze/thawing cycles of solutions of SCI. Both these observations tend to support a low molecular mass for the inhibitor.
It is concluded from the above observations that S . chrestomyeticus produces a compound that inhibits thiol and serine endopeptidases active in the neutral pH range and as such may prove useful as an 'all purpose' protease inhibitor. The compound is of relatively low molecular mass but does not appear to be identical to any of the specific protease inhibitors previously isolated from actinomycetes (Umezawa, 1976 (Umezawa, , 1982 Vol. 14
